Yeping Han

Institute of Life Sciences, Jiyang Colloge of Zhejiang A&F University, Zhuji, 311800, Zhejiang, China
Author    Correspondence author
GMO Biosafety Research, 2024, Vol. 15, No. 6   
Received: 24 Oct., 2024    Accepted: 30 Nov., 2024    Published: 12 Dec., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract This study describes the medical potential of using gene-edited animal organs, such as how CRISPR/Cas9 technology can help reduce immune rejection and reduce the risk of disease transmission. At the same time, the technology raises ethical issues, including animal rights, animal welfare and public acceptance. In terms of regulation, there are large differences between countries, so there is a need to establish uniform international rules and ethical standards. This study explores the need to take ethical issues seriously while promoting scientific progress. In order to support the healthy development of this technology, it is recommended to carry out more practical research, update ethical guidelines, and encourage exchanges and cooperation in different fields.

Gene editing; Xenotransplantation; Ethical controversies; Animal welfare; Regulatory framework